Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1695
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2633
    -0.0005 (-0.04%)
     
  • Bitcoin GBP

    55,964.02
    +1,260.30 (+2.30%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,250.57
    +2.08 (+0.04%)
     
  • DOW

    39,763.41
    +3.33 (+0.01%)
     
  • CRUDE OIL

    82.76
    +1.41 (+1.73%)
     
  • GOLD FUTURES

    2,241.30
    +28.60 (+1.29%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

BUZZ-L'Oreal: is it worth it?

** Aberdeen AM's Bertie Thomson keeping an eye on valuation of L'Oreal, one of many quality cos swept higher by what he calls the "bond-proxy Ponzi scheme" which has lured yield-starved investors into sometimes paying over the odds

** L'Oreal is "fantastic" co with "impossible to replicate" brands, but on c.29x next yr's forecast earnings is "pushing the envelope" of valuation, says Thomson, senior investment manager of FM's Global-European Equity Fund (holder of stock)

** British American Tobacco (LSE: BATS.L - news) (BAT) & drugmaker Roche , on 18x & 20x next yr's forecast earnings respectively, are cos Thomson "more relaxed about" (holds both) amid "genuine valuation risk for a number of equities"

** PM highlights strong customer loyalty to BAT's brands which gives co pricing flexibility, a key consideration when the number of people who smoke in the world is in decline

ADVERTISEMENT

** Roche: mid-single digit FCF yield & high single digit growth rate long-term means c.12 pct combined return which Thomson sees as durable given unique position in oncology & biologic products which are hard to copy

** Also holds Novo Nordisk (Other OTC: NONOF - news) , world's biggest insulin producer; PM flags diabetics' tendency to be loyal to their insulin brand

** As a firm Aberdeen AM manages c.£323 bln of assets

** More on bond proxies: (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)